advertisement

---

Shi J 10

Showing records 1 to 10 | Display all abstracts from Shi J

95797 Baicalin suppresses glaucoma pathogenesis by regulating the PI3K/AKT signaling in vitro and in vivo
Zhao N
Bioengineered 2021; 12: 10187-10198

---

95954 Drugs for the treatment of glaucoma: Targets, structure-activity relationships and clinical research
Wu X; Yang X
European Journal of Medicinal Chemistry 2021; 226: 113842

---

95797 Baicalin suppresses glaucoma pathogenesis by regulating the PI3K/AKT signaling in vitro and in vivo
Shi J
Bioengineered 2021; 12: 10187-10198

---

95954 Drugs for the treatment of glaucoma: Targets, structure-activity relationships and clinical research
Liang Q
European Journal of Medicinal Chemistry 2021; 226: 113842

---

95797 Baicalin suppresses glaucoma pathogenesis by regulating the PI3K/AKT signaling in vitro and in vivo
Xu H; Luo Q
Bioengineered 2021; 12: 10187-10198

---

95954 Drugs for the treatment of glaucoma: Targets, structure-activity relationships and clinical research
Xue X
European Journal of Medicinal Chemistry 2021; 226: 113842

---

95797 Baicalin suppresses glaucoma pathogenesis by regulating the PI3K/AKT signaling in vitro and in vivo
Li Q
Bioengineered 2021; 12: 10187-10198

---

95954 Drugs for the treatment of glaucoma: Targets, structure-activity relationships and clinical research
Huang J
European Journal of Medicinal Chemistry 2021; 226: 113842

---

95797 Baicalin suppresses glaucoma pathogenesis by regulating the PI3K/AKT signaling in vitro and in vivo
Liu M
Bioengineered 2021; 12: 10187-10198

---

95954 Drugs for the treatment of glaucoma: Targets, structure-activity relationships and clinical research
Wang J; Xu Y; Tong R; Liu M; Zhou Q; Shi J
European Journal of Medicinal Chemistry 2021; 226: 113842

---